Measuring the effect of therapy in rheumatoid arthritis clinical trials from the patient's perspective.

The article discusses a study that provided guidelines, tools, and required steps for successful implementation of patient-reported outcome measurement in rheumatoid arthritis (RA) clinical trials. Topics discussed include the core set of endpoints suggested for use in clinical studies of RA, a list of patient-centered domains received from qualitative studies of RA, and two related aspects of work limitations attributed to RA.